You are here: Industry Insights > GlaxoSmithKline

News List

FDA staff question efficacy of GSK’s Nucala for COPD pharmatimes
July 25, 2018
US regulatory advisors are questioning the effectiveness of GlaxoSmithKline’s biologic Nucala as a treatment for patients experiencing a sudden worsening of chronic obstructive pulmonary disorder (COPD).
Is now the time for the GlaxoSmithKline consumer spinoff investors have been waiting for? fiercepharma
July 24, 2018
Back in 2016, GlaxoSmithKline’s then-CEO acknowledged that one day the company might divest its consumer health division. Lately, it’s been looking like that day might not be too far away—and now, there's new evidence a spinoff is brewing.
GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand fiercevaccines
July 23, 2018
GlaxoSmithKline's new shingles vaccine Shingrix quickly captured the market after winning FDA approval and a preferential recommendation from CDC vaccine advisers, but now strong uptake is leading to supply restrictions.
GlaxoSmithKline bids adieu to vaccines President Luc Debruyne as executive overhaul continues fiercevaccines
July 23, 2018
GlaxoSmithKline has experienced multiple top executive departures under CEO Emma Walmsley, but the reformation of the company's leadership isn't finished yet.
GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report fiercevaccines
July 23, 2018
Shingrix may not make it on the top five best-selling vaccines list in 2024, but a diversified portfolio will still secure GlaxoSmithKline the lead position in the vaccine industry at that time, followed by Merck &Co., Sanofi, Pfizer and a dark horse biot
Senators demand more from GlaxoSmithKline to boost Shingrix supply fiercevaccines
July 23, 2018
Amid high demand for GlaxoSmithKline's new shingles vaccine, healthcare providers are running out. Even though the company worked up what it calls a "fair and equitable" process to ship Shingrix doses, two U.S. senators are not satisfied and are urging th
GSK no longer vying for Pfizer’s consumer assets pharmatimes
July 20, 2018
GlaxoSmithKline has revealed that it will not bid for Pfizer’s consumer healthcare business, pulling out of the process just days after rival suitor Reckit Benckiser stepped away from a potential deal.
Senators demand more from GlaxoSmithKline to boost Shingrix supply fiercevaccines
July 10, 2018
Amid high demand for GlaxoSmithKline's new shingles vaccine, healthcare providers are running out. Even though the company worked up what it calls a "fair and equitable" process to ship Shingrix doses
GlaxoSmithKline boosted Shingrix educational efforts after seeing administration, storage errors in launch fiercevaccines
June 26, 2018
Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of expectations
GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand fiercevaccines
June 26, 2018
GlaxoSmithKline's new shingles vaccine Shingrix quickly captured the market after winning FDA approval and a preferential recommendation from CDC vaccine advisers

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page